Company / SG&A per Share
Boston Scientific SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$4.61
FY2025
5-year range
$2.79 / $4.61
FY2021-FY2025
Trend
+14.4%
vs FY2024
Sector context
#89 of 156
Health Care
What the data says
At $4.61, Boston Scientific's sg&a per share ranks #68 of 156 in the Health Care sector. SG&A per Share has increased for 5 consecutive years, from $2.55 in FY2020 to $4.61 in FY2025.
Based on SEC 10-K filings.
4.61 in FY2025 with a 5-year CAGR of +12.6%.
Increased from $3.62 to $4.61 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +13.6%
- 5-Year CAGR
- +12.6%
- 10-Year CAGR
- -
Sector benchmark
#68 of 156 in Health CareTop 43% of 156This company $4.61 Sector average $11421.56
▼
-100.0% below sector average
Key checks
Key Insights
- Boston Scientific's sg&a per share has grown for 5 consecutive years.
- In FY2025, sg&a per share increased 14.4% year-over-year.
- Ranks #89 out of 156 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.61 | +14.4% |
| FY2024 | $4.03 | +11.3% |
| FY2023 | $3.62 | +15.3% |
| FY2022 | $3.14 | +12.4% |
| FY2021 | $2.79 | +9.7% |
| FY2020 | $2.55 | -9.9% |
| FY2019 | $2.83 | +9.6% |
| FY2018 | $2.58 | +7.5% |
| FY2017 | $2.40 | +4.2% |
| FY2016 | $2.30 | +6.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026